comparemela.com

Latest Breaking News On - Maxcyte inc - Page 2 : comparemela.com

Participation in Upcoming Investor Conference | Company Announcement

Investegate announcements from Participation in Upcoming Investor Conference

United kingdomRupert deardenPanmure gordonEmma earl freddy crossleyWilliam blairDavid deuchlerChris welshAnya bolshemMary jane elliottGilmartin groupMaxcyte incAnnual growth stockAnnual growth stock conferenceFlow electroporationCyte contactsJoint corporate

IN BRIEF: MaxCyte inks deal with Legend Biotech for tech supply

IN BRIEF: MaxCyte inks deal with Legend Biotech for tech supply | Financial News

United statesHolly beveridgeMaher masoudMaxcyte incAlliance newsAlliance news ltdLegend biotech corpLegend biotechFlow electroporationExecutive officer maher masoudAll rights

With 64% ownership of the shares, MaxCyte, Inc (LON:MXCT) is heavily dominated by institutional owners

Key Insights Significantly high institutional ownership implies MaxCyte's stock price is sensitive to their trading.

United kingdom generalUnited kingdomBlackrock incMaxcyte inc

MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development

MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United kingdomDavid deuchlerMaher masoudPanmure gordonRupert deardenMary jane elliottAnya bolshemChris welshEmma earl freddy crossleyGilmartin groupMaxcyte incExchange commissionLegend biotechFlow electroporationLicensed productsYing huang phd

Signing of Strategic Platform License | Company Announcement

Investegate announcements from Signing of Strategic Platform License

United kingdomPanmure gordonRupert deardenDavid deuchlerChris welshAnya bolshemMary jane elliottEmma earl freddy crossleyMaher masoudMaxcyte incExchange commissionGilmartin groupCytesignsstrategic platform licenseagreementFlow electroporationLegend biotechLicensed products

vimarsana © 2020. All Rights Reserved.